ROS1 and cancer: Moreover, we have generated a ROS1-positive cancer cell line, starting from a NSCLC that arose in a K-RasG12D mouse, that can be serially transplanted into syngeneic mice, offering an additional tool for studying the potential of ROS1 targeting.